TMDX
TransMedics Group, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
TransMedics Group, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
No other changes.
Last report2 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
Annual filing, covered
10-K parsed · Feb 24 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Feb 24 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
No thesis.
Same SIC code · 6
Same SEC industry code: Medtronic plc, LivaNova PLC, Integer Holdings Corp and 3 more; of TransMedics Group, Inc.'s 6 closest co-movers, none share that code.
Same SIC code · 6
Same SEC industry code: Medtronic plc, LivaNova PLC, Integer Holdings Corp and 3 more; of TransMedics Group, Inc.'s 6 closest co-movers, none share that code.
−5.28%
vs ±15.7% implied · ×0.34
shaded = implied · ▲▼ = realized
TransMedics Group, Inc.
72.72
pre 73.39 +0.87%
Tall tick = annual report · Source: EDGAR
—
—
Bull3
Bear1
| Manager | Value | % base | |
|---|---|---|---|
| BlackRockindex-like | $371.7M | 14.69% | +5.73% |
| FMR | $341.0M | 13.47% | +0.73% |
| Vanguard Portfolioindex-like | $128.5M | 5.08% | +0.75% |
| Vanguardindex-like | $99.5M | 3.93% | +1.32% |
| Susquehanna International | $95.8M | 3.78% | +66.30% |
| Manager | Value | % base | |
|---|---|---|---|
| BlackRockindex-like | $371.7M | 14.69% | +5.73% |
| FMR | $341.0M | 13.47% | +0.73% |
| Vanguard Portfolioindex-like | $128.5M | 5.08% | +0.75% |
| Vanguardindex-like | $99.5M | 3.93% | +1.32% |
| Susquehanna International | $95.8M | 3.78% | +66.30% |
Expected move
Inputs8Q avg ±9.7%·×1.38·rich
spot 72.76exp Nov 6ATM strike 73ATM straddle 11.50IV 267%